Volume 26, Number 11—November 2020
Synopsis
Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017–2019
Benido Impouma
, Maroussia Roelens, George Sie Williams, Antoine Flahault, Claudia Torres Codeço, Fleury Moussana, Bridget Farham, Esther L. Hamblion, Franck Mboussou, and Olivia Keiser
, Maroussia Roelens, George Sie Williams, Antoine Flahault, Claudia Torres Codeço, Fleury Moussana, Bridget Farham, Esther L. Hamblion, Franck Mboussou, and Olivia Keiser
Table 2
Number and frequency of disease outbreaks selected for the study on timeliness of outbreak milestones in the WHO African Region, 2017–2019
| Outbreaks | Disease category | No. (%) outbreaks |
|---|---|---|
| Cholera | Food/waterborne | 55 (18.6) |
| Measles | Vaccine-preventable | 33 (11.1) |
| Dengue fever | Vectorborne | 23 (7.8) |
| Crimean-Congo hemorrhagic fever | Viral hemorrhagic fever | 22 (7.4) |
| Poliomyelitis (circulating vaccine-derived poliovirus type2) | Vaccine-preventable | 17 (5.7) |
| Meningococcal disease | Vaccine-preventable | 16 (5.4) |
| Lassa fever | Viral hemorrhagic fever | 15 (5.1) |
| Anthrax | Other | 13 (4.4) |
| Monkeypox | Other | 12 (4.1) |
| Rift Valley fever | Viral hemorrhagic fever | 12 (4.1) |
| Yellow fever | Vaccine-preventable | 11 (3.7) |
| Malaria | Vectorborne | 10 (3.4) |
| Plague | Vectorborne | 6 (2.0) |
| Chikungunya | Vectorborne | 6 (2.0) |
| Hepatitis E | Food/waterborne | 5 (1.7) |
| Ebola virus disease | Viral hemorrhagic fever | 5 (1.7) |
| Typhoid fever | Food/waterborne | 4 (1.4) |
| Acute bloody diarrhea | Food/waterborne | 4 (1.4) |
| Pertussis | Vaccine-preventable | 3 (1.0) |
| Food--borne | Food/waterborne | 3 (1.0) |
| Listeriosis | Food/waterborne | 2 (0.7) |
| Influenza A(H1N1) | Other | 2 (0.7) |
| Rubella | Vaccine-preventable | 2 (0.7) |
| Aflatoxicosis | Food/waterborne | 2 (0.7) |
| Guinea worm disease | Other | 2 (0.7) |
| Marburg | Viral hemorrhagic fever | 2 (0.7) |
| Leishmaniasis | Vectorborne | 2 (0.7) |
| Botulism | Food/waterborne | 1 (0.3) |
| Adverse effect following immunization | Other | 1 (0.3) |
| Hepatitis A | Vaccine-preventable | 1 (0.3) |
| Rotavirus | Vaccine-preventable | 1 (0.3) |
| Zika virus disease | Vectorborne | 1 (0.3) |
| Diphtheria | Vaccine-preventable | 1 (0.3) |
| Scabies |
Other |
1 (0.3) |
| Total | 296 (100.0) |
Page created: July 31, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.